(Q47877204)

English

Immunogenicity and safety of the candidate RTS,S/AS01 vaccine in young Nigerian children: a randomized, double-blind, lot-to-lot consistency trial.

scientific article published on 28 July 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

Immunogenicity and safety of the candidate RTS,S/AS01 vaccine in young Nigerian children: a randomized, double-blind, lot-to-lot consistency trial. (English)

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

Opokua Ofori-Anyinam

13

object named as

Opokua Ofori-Anyinam

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

12

object named as

Marc Lievens

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

author name string

Rich Umeh

1

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

Stephen Oguche

2

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

Tagbo Oguonu

3

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

Simon Pitmang

4

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

Elvis Shu

5

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

Jude-Tony Onyia

6

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

Comfort A Daniyam

7

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

David Shwe

8

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

Abdullahi Ahmad

9

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

Erik Jongert

10

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

Grégory Catteau

11

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

Amanda Leach

14

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

language of work or name

0 references

publication date

28 July 2014

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

32

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

48

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

6556-6562

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

The RTS,S vaccine candidate for malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.067

7 January 2021

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.067

7 January 2021

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.067

7 January 2021

Pooled analysis of safety data from pediatric Phase II RTS,S/AS malaria candidate vaccine trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.067

7 January 2021

Ensuring the optimal safety of licensed vaccines: a perspective of the vaccine research, development, and manufacturing companies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.067

7 January 2021

Food and Drug Administration regulation and evaluation of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.067

7 January 2021

A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.067

7 January 2021

Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.067

7 January 2021

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.067

7 January 2021

Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.067

7 January 2021

Genetic regulation of immune responses to vaccines in early life

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.067

7 January 2021

Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.067

7 January 2021

The link between genetic variation and variability in vaccine responses: systematic review and meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.067

7 January 2021

Identifiers

10.1016/J.VACCINE.2014.07.067

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/25077418

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47877204&oldid=1429451110"